Clicky

Merck & Company Inc(MRK) News

Date Title
Jul 28 Merck & Co., Inc.'s (NYSE:MRK) Dismal Stock Performance Reflects Weak Fundamentals
Jul 26 Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma
Jul 24 MSD reports positive topline data from Phase IIb/III RSV trial in infants
Jul 23 Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
Jul 23 Merck Announces Fourth-Quarter 2024 Dividend
Jul 23 Should You Buy, Sell or Hold Merck (MRK) Ahead of Q2 Earnings?
Jul 23 Billionaires Are Loading Up on This Surging Dow Stock. Should You?
Jul 23 Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 78% of the company
Jul 23 Merck claims late-stage study success for RSV antibody
Jul 23 Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants
Jun 25 USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
Jun 25 ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
Jun 24 Merck (MRK) Increases Despite Market Slip: Here's What You Need to Know
Jun 24 Is Merck & Co., Inc. (MRK) a Strong Buy Right Now?
Jun 22 With 78% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners
Jun 21 The 30-stock secret: ‘Don’t fight Papa Dow’
Jun 20 Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center
Apr 7 10 Best Weight Loss Drug Stocks to Buy Now
Apr 6 The three-year decline in earnings for Merck NYSE:MRK) isn't encouraging, but shareholders are still up 93% over that period
Apr 5 Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing